Name
Alithea Genomics
What We Do
Alithea Genomics develops high-throughput RNA sequencing solutions that make transcriptomic profiling scalable, cost-efficient, and practical for toxicology and drug discovery. Its MERCURIUS™ portfolio of kits and services enables researchers to measure gene expression across hundreds to thousands of samples.

MERCURIUS™ DRUG-seq combines extraction-free sample preparation with early multiplexing and automation-ready workflows to support compound screening, dose-response studies, and mechanism-of-action analysis. Researchers can characterize molecular responses, identify affected pathways, and investigate toxicity-associated signatures across compounds, concentrations, and time points. For studies requiring a more comprehensive readout, Total DRUG-seq captures coding and non-coding transcripts and supports isoform and alternative splicing analysis.

With laboratory services in Switzerland and the United States, Alithea helps research teams integrate transcriptomics into discovery and safety assessment workflows.
Category (15)
Agrochemical Product Safety/Toxicology, Biomarkers, Biotechnology Products, Biotechnology Research/Testing, CRO—Contract Research Organization, Chemical Product Safety/Toxicology, High Throughput Test Systems, Pesticide Product Safety/Toxicology, Pharmaceutical Product Safety/Toxicology
Address
Rue de la Corniche 8
Lausanne,
Switzerland

Share: